Related Experiment Videos
[Preventive strategies for nosocomial pneumonia]
Kazui Soma1, Hiroshi Imai, Masayasu Arai
1Department of Emergency and Critical Care Medicine, Kitasato Univerisity, School of Medicine, Kanagawa, Japan.
Nihon Geka Gakkai Zasshi
|November 30, 2004
Summary
Ventilator-associated pneumonia (VAP) is a critical complication. Early ventilator removal, non-invasive ventilation, and prompt, de-escalated antibiotic therapy improve outcomes for VAP patients.
Area of Science:
- Critical care medicine
- Infectious diseases
- Respiratory therapy
Context:
- Ventilator-associated pneumonia (VAP) is a significant nosocomial infection.
- Occurs >48 hours after endotracheal intubation and mechanical ventilation.
- A major infectious complication in the perioperative period.
Purpose:
- To review the epidemiology, risk factors, pathogenesis, diagnosis, treatment, and prophylaxis of VAP.
- To highlight key strategies for VAP prevention and management.
Summary:
- VAP definition: nosocomial pneumonia >48h post-intubation/ventilation.
- Prevention: early ventilator liberation, non-invasive ventilation, subglottic suctioning, and oral care.
- Treatment: early appropriate antimicrobial therapy with subsequent de-escalation based on microbiological data.
Impact:
- Informing clinical practice for VAP prevention and treatment.
- Reducing VAP incidence and improving patient outcomes.
- Guiding antimicrobial stewardship in mechanically ventilated patients.